Novel mechanism to enhance tPA-induced fibrinolysis: Effect of limited proteolysis of PAI-1 by neutrophil elastase

Polish Journal of Pharmacology

Volumn 48, Issue 2, 1996, Pages 209-213

  Urano, Tetsumei ^a   Wu, Kai ^a   Ihara, Hayato ^a   Takada, Yumiko ^a   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibrinolysis; Human neutrophil elastase; PAI 1; tPA

Indexed keywords

LEUKOCYTE ELASTASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; VITRONECTIN;

AMINO TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONFERENCE PAPER; ENZYME ACTIVITY; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; MOLECULAR WEIGHT; NEUTROPHIL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FIBRINOLYSIS; HUMANS; LEUKOCYTE ELASTASE; MOLECULAR SEQUENCE DATA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030056804     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Carrel R. W., Boswell D. R.: Serpins: The super-family of plasma serine protease inhibitors In: Proteinase Inhibitors. Eds. Barret A., Salvensen G., Elsevier, Amsterdam, 1986, 403-420.
2. Castellino F. J.: Recent advances in the chemistry of the fibrinolytic system. Chem. Rev., 1981, 81, 431-446.
3. Dombret H., Scrobohaci M. L., Ghorra P., Zini J. M., Daniel M. T., Castaigne S., Degos L.: Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Leukemia, 1993, 7, 2-9.
4. Gramse M., Egbring R., Havemann K.: Alpha 2-plasmin inhibitor inactivation by human granulocyte elastase. Hoppc Seylers Z. Physiol. Chem., 1984 365, 19-26.
5. Levin E. G., Santell L.: Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J. Cell. Biol., 1987, 105, 2543-2549.
6. Loskutoff D. J., Sawdey M., Mimuro J.: Type 1 plasminogen activator inhibitor. Prog. Hemost. Thromb., 1989, 9, 87-115.
7. Machovich R., Owen W. G.: An elastase-dependent pathway of plasminogen activation. Biochemistry, 1989, 28, 4517-4522.
8. Moroz L. A.: Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase. Blood, 1981 58, 97-104.
9. Mottonen J., Strand A., Symersky J., Sweet R. M., Danley D. E., Geoghegan K. F., Gerard R. D., Goldsmith E. J.: Structural basis of latency in plasminogen activator inhibitor-1. Nature, 1992, 355, 270-273.
10. Ny T., Sawdey M., Lawrence D., Millan J. L., Loskutoff D. J.: Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc. Nat. Acad. Sci. USA, 1986, 83, 6776-6780.
11. Plow E. F.: The major fibrinolytic proteases of human leukocytes. Biochim. Biophys. Acta, 1980, 630, 47-56.
12. Sakata Y., Murakami T., Noro A., Mori K., Matsuda M.: The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood, 1991, 77, 1949-1957.
13. Urano T., Sakakibara K., Rydzewski A., Urano S., Takada Y., Takada A.: Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1. Thromb. Haemost., 1990, 63, 82-86.
14. Urano T., Strandberg L., Johansson L. B., Ny T.: A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. Eur. J. Biochem., 1992, 209, 985-992.
15. Urano T., Sumiyoshi K., Pietraszek M. H., Takada Y., Takada A.: PAI-1 plays an important role in the expression of t-PA activity in the euglobulin clot lysis by controlling the concentration of free t-PA. Thromb Haemost., 1991, 66, 474-478.